REGN vs SGBX · P/E 14, rev $4.29B vs rev $5.0M
Regeneron Pharmaceuticals Inc (REGN) versus SG Blocks Inc (SGBX) — a side-by-side from cached financials, not a winner call.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US. It is led by Leonard S. Schleifer M.D., Ph.D..
SG Blocks Inc (SGBX) is a metal fabrication company listed on NASDAQ.
Latest reported REGN revenue for 2026-06-30 was $4.29B. Net income was $1.30B. Revenue was up 19.0% from 2026-03-31 to 2026-06-30. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Latest reported SGBX revenue for 2024-12-31 was $5.0M. Net income was -$17.0M. Revenue was down 69.9% from 2023-12-31 to 2024-12-31. SGBX currently screens at market cap $9.3M.
REGN currently screens at market cap $59.10B and trailing P/E 13.9. SGBX currently screens at market cap $9.3M.
Not investment advice. Open the REGN and SGBX stock pages for the full models.
Not investment advice.